Latest News & Features
Americas
Teva and South Korean biopharmaceutical company Celltrion have entered into an exclusive partnership to commercialise two of Celltrion’s biosimilars in the US and Canada. 7 October 2016
Americas
Hedge fund manager Kyle Bass has lost a patent case against Shire over the drug Lialda. 7 October 2016
Americas
Amgen has filed complaints against Indian pharmaceutical companies Dr Reddy’s and Ajanta Pharma for allegedly infringing a patent centring on its drug Sensipar. 6 October 2016
Big Pharma
Teva has agreed to sell certain assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare, a subsidiary of Indian generics firm Intas Pharmaceuticals. 6 October 2016
Europe
Law firm McDermott Will & Emery has appointed Henrik Holzapfel as a partner in its Düsseldorf, Germany office. 6 October 2016
Americas
Enzo Life Sciences, a distributor of life sciences products, has filed a complaint against diagnostics supplier Hologic for allegedly infringing a patent centring on several technologies. 5 October 2016
Asia
Myanmar authorities have seized K2.8 billion worth of counterfeit and expired drugs. 5 October 2016
Americas
US pharmaceutical company Depomed has won a patent case in the US District Court for the District of New Jersey against three filers of Abbreviated New Drug Applications covering Nucynta. 4 October 2016
Americas
Allergan and MedImmune have entered into a $1.52 billion licensing agreement under which Allergan has gained the global rights to develop MEDI2070, which treats inflammatory disorders. 4 October 2016
Americas
The $3.6 billion acquisition of the Thomson Reuters Intellectual Property & Science business by Onex Corporation and Baring Equity Asia was completed yesterday. 4 October 2016